Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values

European Journal of Surgical Oncology

Volumn 40, Issue 11, 2014, Pages 1528-1532

  Brindle, R ^a   Mullan, D ^b   Yap, B K ^b   Gandhi, A ^c  

^a North West Deanery ^*  (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

18F Fluorodeoxy glucose (FDG) Positron emission tomography computed tomography; Standardised uptake values; Thyroid cancer; Thyroid incidentaloma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; BENIGN TUMOR; CANCER CENTER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYTOLOGY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION MEASUREMENT; STANDARDISED UPTAKE VALUE; TERTIARY CARE CENTER; THYROID GLAND; THYROID INCIDENTALOMA; ADENOCARCINOMA; CARCINOMA; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; INCIDENTAL FINDING; LYMPHOMA; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; AGED; CARCINOMA; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; LYMPHOMA; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84922479593     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.05.005     Document Type: Article

References (19)

1. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 2009;30(3):240-4.
2. Kurata S, Ishibashi M, Hiromatsu Y, et al. Diffuse and diffuse-plusfocal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis. Ann Nucl Med 2007;21(6):325-30. http://dx.doi.org/10.1007/s12149-007-0030-2. [accessed 01.03.12].
3. Hsiao Y-C, Wu P-S, Chiu N-T, Yao W-J, Lee B-F, Peng S-L. The use of dual phase 18-F FDG PET in characterizing thyroid incidentalomas. Clin Radiol 2011;66(12):1197-202.
4. Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006;47(4):609-15.
5. Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 2009;30(9):742-8.
6. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88(9):4100-4.
7. Kao YH, Lim SS, Ong SC, Padhy AK. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomographycomputed tomography: incidence, malignancy risk, and comparison of standardized uptake values. Can Assoc Radiol J 2012;63(4):289-93. http://dx.doi.org/10.1016/j.carj.2011.04.003.
8. Huang SC. Anatomy of SUV: standardized uptake value. Nucl Med Biol 2000;27(7):643-6.
9. Pagano L, Samá MT, Morani F, et al. Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf). 2011;75(4):528-34. http://dx.doi.org/10.1111/j.1365-2265.2011.04107.x.
10. Bae JS, Chae BJ, Park WC, et al. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol 2009;7:63.
11. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope; 115(6):1074-8.
12. Eloy JA, Brett EM, Fatterpekar GM, et al. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. AJNR Am J Neuroradiol 2009;30(7):1431-4. http://dx.doi.org/10.3174/ajnr. A1559.
13. National Health Service. NHS choices: health AeZ: PET scan. http://www.nhs.uk/conditions/PET-scan/Pages/Introduction. aspx. [accessed 01.10.12].
14. Bogsrud TV, Karantanis D, Nathan MA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 2007;28(5):373-81.
15. Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol 2007;14(11):3210-5.
16. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001;130(6):941-6.
17. Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005;25(2 B):1421-6.
18. Zhai G, Zhang M, Xu H, Zhu C, Li B. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma. J Endocrinol Invest 2010;33(3):151-5.
19. D'Souza MM, Marwaha RK, Sharma R, et al. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography. Ann Nucl Med 2010;24(5):345-55.